Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 1,384,300 | 1,263,100 | 1,203,300 | 1,140,400 | 1,128,800 |
| Cost of Goods | 114,300 | 95,200 | 99,200 | 85,800 | 96,800 |
| Gross Profit | 1,270,000 | 1,167,900 | 1,104,100 | 1,054,600 | 1,032,000 |
| Operating Expenses | 729,300 | 638,100 | 571,700 | 538,600 | 989,100 |
| Operating Income | 541,000 | 530,000 | 532,600 | 516,800 | 43,700 |
| Interest Expense | 21,700 | 17,900 | 18,300 | 19,900 | 24,500 |
| Other Income | 82,700 | 23,400 | -14,800 | 44,900 | -52,100 |
| Pre-tax Income | 602,000 | 535,500 | 499,500 | 541,800 | -32,900 |
| Income Tax | -287,000 | 67,900 | 39,700 | -46,100 | 12,100 |
| Net Income Continuous | 889,000 | 467,600 | 459,800 | 587,900 | -45,000 |
| Net Income | $889,000 | $467,600 | $459,800 | $587,900 | $-45,000 |
| EPS Basic Total Ops | 4.00 | 2.09 | 2.05 | 2.63 | -0.20 |
| EPS Basic Continuous Ops | 4.00 | 2.09 | 2.05 | 2.63 | -0.20 |
| EPS Diluted Total Ops | 3.97 | 2.08 | 2.04 | 2.61 | -0.18 |
| EPS Diluted Continuous Ops | 3.97 | 2.08 | 2.04 | 2.61 | -0.19 |
| EPS Diluted Before Non-Recurring Items | 2.51 | 2.55 | N/A | N/A | N/A |
| EBITDA(a) | $631,600 | $622,500 | $629,100 | $614,000 | $155,600 |